FDA Floats Plan For Streamlined Device Evaluation
The U.S. Food and Drug Administration on Wednesday unveiled a draft proposal for streamlining approval of medical devices, saying it wants to standardize tools used in clinical trials to measure product...To view the full article, register now.
Already a subscriber? Click here to view full article